发明名称 INTRANASAL ADMINISTRATION OF PHYSOSTIGMINE AND ARECOLINE
摘要 TITLE INTRANASAL ADMINISTRATION OF PHYSOSTIGMINE AND ARECOLINE The intranasal administration of arecoline and physostigmine is provided for the treatment of a cognitive deficiency. Such administration of physostigmine is also used to treat overdoses of anticholinergic drugs or to protect a mammal against organophosphate poisoning. Intranasal delivery of these drugs offers a convenient dosage form with efficient bioavailability.
申请公布号 CA2012192(A1) 申请公布日期 1990.09.28
申请号 CA19902012192 申请日期 1990.03.14
申请人 DU PONT (E. I.) DE NEMOURS AND COMPANY 发明人 HUSSAIN, MUNIR A.;MOLLICA, JOSEPH A.
分类号 A61K9/08;A61K9/00;A61K9/107;A61K31/40;A61K31/44;A61P25/28;A61P39/02;(IPC1-7):A61K31/455 主分类号 A61K9/08
代理机构 代理人
主权项
地址